Homozygous beta zero-39 mutation with thalassemia intermedia in northern Sardinia: clinical, hematological and molecular analysis

Hemoglobin. 1988;12(5-6):673-80. doi: 10.3109/03630268808991660.

Abstract

In this study, we investigated the clinical and hematological features and carried out alpha- and beta-globin gene analyses in 11 Sardinian adult beta zero-thalassemia homozygotes from Northern Sardinia who were not transfusion-dependent. Oligonucleotide analysis revealed in nine out of 11 patients the nonsense mutation at codon 39, which was associated either with haplotype II or IX (14/16 and 2/16 chromosomes, respectively). Haplotype II was linked to the A gamma T mutation. The G gamma globin level ranged from 50 to 70%. Four out of nine patients (44%) were heterozygous and 3/9 (33%) homozygous for the rightward deletional type of alpha-thalassemia; two (22%) had the normal alpha-gene complement. Patients who were alpha-thalassemia homozygotes (-alpha/-alpha) showed a more balanced globin chain synthesis ratio. This study confirms that alpha-thalassemia may ameliorate the clinical picture of homozygous beta zero-thalassemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Genotype
  • Hemoglobins / analysis
  • Homozygote*
  • Humans
  • Italy
  • Mutation*
  • Polymorphism, Restriction Fragment Length
  • Thalassemia / blood
  • Thalassemia / genetics*

Substances

  • Hemoglobins